蓝丝带委员会II:提升外科教育与培训的当代评估与建议
蓝丝带委员会II由67名外科教育专家组成,通过德尔菲法(共识阈值≥80%)确定并推荐2024年外科教育的31项优先事项,下设多个小组委员会分别撰写发现与建议报告,并征求了住院医师和专科培训医师焦点小组的反馈。
要点
- BRC II使用德尔菲法,共识定义为≥80%同意。
- 委员会识别并推荐2024年外科教育31项优先事项。
- 下设小组委员会涵盖评估、劳动力、医学生教育等九个领域。
核心结论
- BRC II小组委员会报告提供了2024年外科教育与培训的评估和关键建议。
研究设计与样本
- BRC II由67名基于外科教育与培训经验和领导力选出的专家组成,分为多个小组委员会,每个小组委员会负责撰写其发现和建议的手稿。
- BRC II采用德尔菲法,共识定义为同意率≥80%。
主要发现
- BRC II识别并推荐了2024年外科教育的31项优先事项。
- 初步发现提交给普外科及相关专科住院医师和专科培训医师焦点小组征求意见和书面反馈,并要求他们也准备一份手稿。
关键数值与推荐
- 德尔菲法共识阈值:≥80%。
- 推荐优先事项数量:31项(2024年外科教育)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Provide reports of the Blue Ribbon II Subcommittees. BACKGROUND: The Blue Ribbon Committee II (BRC II) was a panel of 67 experts selected on the basis of experience and leadership in surgical education and training. METHODS: It was organized into subcommittees, each of which was asked to prepare a manuscript on their findings and recommendations. The BRC II Subcommittees were: Blue Ribbon Committee 1 Review and Assessment, Surgical Workforce, Medical Student Education, Work Life Integration, Resident Education, Goals, Structure and Financing of Training, Education Support and Faculty Development, Research Training, and Educational Technology and Assessment. BRC II used the Delphi approach with consensus defined as equal to or greater than 80% and identified and recommended 31 priorities for surgical education in 2024. RESULTS: The initial findings were presented to a general surgery and related specialty resident and fellow focus group for comments and written feedback, and they were asked to prepare a manuscript as well. CONCLUSIONS: The reports of the Subcommittees of the BRC II provide an assessment and key recommendations concerning surgical education and training in 2024.
引用
- Ellison EC, Stain SC, Lillemoe KD, et al. Introduction to the Contemporary Assessment and Recommendations to Enhance Surgical Education and Training: Reports of the Subcommittees of the Blue Ribbon Committee II. Ann Surg. 2024. PMID: 39109426. doi:10.1097/SLA.0000000000006495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。